APOE4 and myelin: Wnt signaling offers a research target in laboratory models
Published in Biology, Brain/Neurology, Diseases!, Journals.
Published October 15, 2026.
MIT researchers report a possible explanation for how the Alzheimer’s-associated APOE4 variant disrupts myelin, the fatty insulation around nerve fibers. Their study, published October 15 in Cell Stem Cell, links APOE4 to reduced Wnt signaling in oligodendrocytes, the cells that produce myelin.
A genome-wide CRISPR screen in human cell cultures helped identify this pathway. When Wnt signaling was restored in laboratory models, lipid-droplet accumulation decreased and myelination improved. In mice carrying APOE4 and modeling tau pathology, the experimental compound CHIR99021 reduced hippocampal lipid droplets and increased myelination relative to untreated controls.
Evidence limits: These are cell-culture and animal results, not evidence of an effective Alzheimer’s treatment in people. Restoring myelin in a model does not establish cognitive benefit, safe dosing or long-term safety in patients.
Sources: MIT research release, republished by Medical Xpress, October 15, 2026; Cell Stem Cell study.